Hepatocyte growth factor protects endothelial cells against gamma ray irradiation-induced damage

Acta Pharmacologica Sinica

Volumn 30, Issue 10, 2009, Pages 1415-1420

  Hu, Shun Ying ^a   Duan, Hai Feng ^b   Li, Qing Fang ^b   Yang, Yue Feng ^b   Chen, Jin Long ^b   Wang, Li Sheng ^b   Wang, Hua ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Apoptosis; Endothelial cell; Hepatocyte growth factor; Irradiation induced damage; Migration; Proliferation

Indexed keywords

SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; FLOW CYTOMETRY; GAMMA RADIATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

APOPTOSIS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FORMAZANS; GAMMA RAYS; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-MET; TETRAZOLIUM SALTS; TIME FACTORS; UMBILICAL VEINS;

EID: 70350641537     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.133     Document Type: Article

References (33)

1. Stewart JR, Fajardo LF, Gillette SM, Constine LS. Radiation injury to the heart. Int J Radiat Oncol Biol Phys 1995; 31: 1205-1211
2. Schultz-Hector S, Sund M, Thames HD. Fractionation response and repair kinetics of radiation-induced heart failure in the rat. Radiother Oncol 1992; 23: 33-40.
3. Gustavsson A, Eskilsson J, Landberg T, Svahn-Tapper G, White T, Wollmer P, et al. Late cardiac effect after mantle radiotherapy in patients with Hodgkin's disease. Ann Oncol 1990; 1: 355-363
4. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 1993; 11: 1208-1215
5. Reinders JJ, Heijmen BJ, Olofsen-van Acht MJ, van Putten WL, Levendag PC. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 1999; 51: 35-42.
6. Early Breast Cancer Trialist's. Favorable and unfavorable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2000; 355: 1757-1770
7. Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst 2007; 99: 206-214
8. Fajardo LF, Stewart JR. Experimental radiation-induced heart disease. Light microscopic studies. Am J Pathol 1970; 59: 299-316.
9. Lauk S. Endothelial alkaline phosphatase activity loss as an early stage in the development of radiation-induced heart disease in rats. Radiat Res 1987; 110: 118-128
10. Jaenke RS, Robbins MEC, Bywaters T, Whitehouse E, Rezvani M, Hopewell JW. Capillary endothelium. Target site if renal radiation injury. Lab Invest 1993; 68: 396-405.
11. Lauk S, Kiszel Z, Buschmann J, Trott KR. Radiation-induced heart disease in rats. Int J Radiat Oncol Biol Phys 1985; 11: 801-808
12. Schultz-Hector S, Balz K. Radiaton-induced loss of endothelial alkaline phosphatase activity and development of myocardial degeneration. An ultrastructural study. Lab Invest 1994; 71: 252-260
13. Boerma M, Kruse JJ, van Loenen M, Klein HR, Bart CI, Zurcher C, et al. Increased deposition of von Willebrand factor in the rat heart after local ionizing irradiation. Strahlenther Onkol 2004; 180: 109-116
14. Wondergem J, van der Laarse A, van Ravels FJ, van Wermeskerken AM, Verhoeve HR, de Graaf BW, et al. In vitro assessment of cardiac performance after irradiation using an isolated working rat heart preparation. Int J Radiat Biol 1991; 59: 1053-1068
15. Franken NA, Camps JA, van Ravels FJ. Comparison of in vivo cardiac function with ex vivo cardiac performance of the rat heart after thoracic irradiation. Br J Radiol 1997; 70: 1004-1009
16. Aoyama T, Takimoto Y, Pennica D, Inoue R, Shinoda E, Hattori R, et al. Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. T Mol Cell Cardiol 2000; 32: 1821-1830
17. Schneider MD, Schwartz RJ. Chips ahoy: gene expression in failing hearts surveyed by high-density microarrays. Circulation 2000; 102: 3026-3027
18. Peterson D, Ju H, Hao J, Chapman DC, Dixon IM. Expression if Gia2 and Gsa in myofibroblasts localized to the infarct scar in heart failure due to myocardial infarction. Cardiovasc Res 1998; 41: 575-585
19. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J cell Biol 1995; 129: 1177-1180
20. Mizuno S, Matsumoto K, Nakamura T. HGF as a renotrophic and antifibrotic regulator in chronic renal disease. Front Biosci 2008; 13: 7072-7086
21. Birchmeier C, Gherardi E. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 1998; 8: 404-410
22. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-41.
23. van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, et al. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998; 97: 381-390
24. Anki M, Morishta R, Taniyama Y, Kida I, Moriguchi A, Matsumoto K, et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infracted myocardium; up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther 2000; 7: 417-427
25. Fajardo LF, Stewart JR. Pathogenesis of radiation-induced myocardial fibrosis. Lab Invest 1973; 29: 244-257
26. Hu SY, Qiu L, Duan HF, Wang H, Wang RL, Guo ZK, et al. Hepatocyte growth factor protects cultured rat cardiomyocytes against apoptosis induced by gamma ray irradiation. Med J Chin People Liberation Army 2007, 32: 482-484 Chinese.
27. Yo Y, Morishita R, Nakamura S, Tomita N, Yamamoto K, Moriguchi A, et al. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on the epithelial cells. Kidney Int 1998; 54: 1128-1138
28. Kosai K, Matsumoto K, Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 1999; 30: 151-159
29. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 1997; 95: 2552-2558
30. Matsumori A, Furukawa Y, Hashimoto T, Ono K, Shioi T, Okada M, et al. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun 1996; 221: 391-395
31. Sato T, Yoshinouchi T, Sakamoto T, Fujieda H, Murao S, Sato H, et al. Hepatocyte growth factor(HGF): a new biochemical marker for acute myocardial infarction. Heart Vessels 1997; 12: 241-246
32. Schaper W, Kubin T. Is hepatocyte growth factor a protein with cardioprotective activity in the ischemic heart? Circulation 1997; 95: 2471-2472
33. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993; 90: 1937-1941